person

Johan I.

Country
Sweden
Department
VO Internmedicin, Lungenheten

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
283
Sites with multiple studies

Has run more than one trial at 283 of 501 partner sites.

Specializations

Small Cell Lung Cancer Research

The investigator specializes in studying therapeutic approaches for small cell lung cancer (SCLC), with particular focus on both limited and extensive disease stages. Their research encompasses innovative combinations of chemoradiotherapy and immunotherapy treatments.

  • Limited Disease SCLC Management
  • Extensive Stage SCLC Treatment
  • Thoracic Radiotherapy Applications

Interest extends to integrating concurrent treatment modalities for optimal patient outcomes.

Non-Small Cell Lung Cancer Innovation

Primary research focus includes advanced non-small cell lung cancer (NSCLC), particularly investigating novel therapeutic combinations and targeted treatments for specific mutations.

  • KRAS G12C-Positive NSCLC
  • EGFR-Mutated NSCLC
  • Metastatic NSCLC Treatment

Expertise in evaluating targeted therapies and their sequencing for optimal treatment outcomes.

Immunotherapy Applications

Concentrated work in the field of immunotherapy combinations for lung cancer treatment, including studies with various immunotherapeutic agents and their integration with conventional therapies.

  • Combined Immunotherapy Approaches
  • Biomarker-Guided Treatment
  • Novel Therapeutic Combinations

Focus on developing personalized treatment strategies based on specific cancer characteristics.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.